Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
302 studies found for:    "cyclic neutropenia" OR "Neutropenia"
Show Display Options
RSS Create an RSS feed from your search for:
"cyclic neutropenia" OR "Neutropenia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Intervention: Biological: Filgrastim
2 Completed GCPGC in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Biological: GCPGC 3.6mg;   Biological: GCPGC 6mg;   Biological: Neulasta (pegfilgrastim) 6mg
3 Recruiting Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
Condition: Neutropenia
Interventions: Drug: pegfilgrastim,30mcg/kg;   Drug: pegfilgrastim, 60mcg/kg;   Drug: pegfilgrastim, 100mcg/kg;   Drug: filgrastim, 5mcg/kg
4 Completed
Has Results
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
Condition: Febrile Neutropenia
Intervention:
5 Completed Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Condition: Neutropenia
Interventions: Drug: HM10460A (45 μg/kg);   Drug: HM10460A (135 μg/kg);   Drug: HM10460A (270 μg/kg);   Drug: Pegfilgrastim 6mg
6 Completed Screening for Genes in Patients With Congenital Neutropenia
Condition: Congenital Neutropenia
Intervention: Genetic: High-throughput exome sequencing
7 Terminated Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Intervention: Drug: Ezatiostat Hydrochloride
8 Completed Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Empirical antimicrobial treatment discontinuation;   Other: Standard empirical antimicrobial treatment discontinuation
9 Completed A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
Condition: Neutropenia
Intervention:
10 Terminated
Has Results
Daptomycin Versus Placebo in Patients With Neutropenia and Fever
Condition: Febrile Neutropenia
Interventions: Drug: Daptomycin;   Other: Saline Placebo
11 Withdrawn Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Early antibiotic discontinuation;   Other: Usual practice
12 Recruiting Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
Condition: Febrile Neutropenia
Intervention:
13 Completed
Has Results
Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
Condition: Febrile Neutropenia
Intervention: Drug: Antibacterial agent for the treatment of febrile neutropenia
14 Not yet recruiting ANF-Rho in the Treatment of Chronic Neutropenia
Condition: Neutropenia, Severe Chronic
Intervention: Drug: ANF-Rho
15 Completed Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Drug: PEG-G-CSF;   Drug: G-CSF
16 Completed Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Drug: PEG-G-CSF;   Drug: G-CSF
17 Recruiting Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study
Condition: Chemotherapy-Induced Neutropenia
Intervention: Biological: Nivestim®
18 Completed Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Conditions: MBL-Deficient;   Neutropenia
Interventions: Drug: Mannan Binding Lectin (MBL);   Drug: Mannan Binding Lectin
19 Completed
Has Results
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Condition: Chemotherapy-induced Neutropenia
Interventions: Biological: empegfilrastim;   Biological: filgrastim
20 Completed
Has Results
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Condition: Chemotherapy-induced Neutropenia
Interventions: Biological: Empegfilrastim 6 mg;   Biological: Filgrastim;   Biological: Placebo №1;   Biological: Placebo №2;   Biological: Empegfilrastim 7.5 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.